{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:32:42Z","timestamp":1785583962996,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurgcases.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery Cases, Innovations and Techniques"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jvscit.2025.101824","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T02:12:18Z","timestamp":1745806338000},"page":"101824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Drug-associated abdominal aortitis and retroperitoneal fibrosis after treatment with nivolumab"],"prefix":"10.1016","volume":"11","author":[{"given":"Naomi","family":"Wedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Cormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6136-0179","authenticated-orcid":false,"given":"Kenton","family":"Rommens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvscit.2025.101824_bib1","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.3390\/ijms24065643","article-title":"Rheumatic immune-related adverse events due to immune checkpoint inhibitors-A 2023 update","volume":"24","author":"Dang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jvscit.2025.101824_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jvscit.2025.101824_bib3","article-title":"Immune checkpoint inhibitor-associated cardiovascular toxicities: a review","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jvscit.2025.101824_bib4","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvscit.2025.101824_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13691-024-00668-4","article-title":"An underrecognized association: immune checkpoint inhibitor-related aortitis, a case report with the review of the literature","volume":"13","author":"Y\u0131ld\u0131r\u0131m","year":"2024","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.jvscit.2025.101824_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221852","article-title":"Aftermath of induced inflammation: acute periaortitis due to nivolumab therapy","volume":"2017","author":"Roy","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jvscit.2025.101824_bib7","first-page":"171","article-title":"Subclinical aortitis after starting nivolumab in a patient with metastatic melanoma. A case of drug-associated aortitis?","volume":"36","author":"Loricera","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jvscit.2025.101824_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/RLU.0000000000003215","article-title":"Nivolumab-Induced periaortitis demonstrated by FDG PET\/CT","volume":"45","author":"Hotta","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jvscit.2025.101824_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233496","article-title":"Immune checkpoint inhibitor induced large vessel vasculitis","volume":"13","author":"Henderson","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jvscit.2025.101824_bib10","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.57187\/s.3631","article-title":"Successful treatment of immune checkpoint inhibitor-related periaortitis","volume":"154","author":"B\u00fchrer","year":"2024","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jvscit.2025.101824_bib11","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s00405-024-08495-2","article-title":"Aortic rupture following acute aortitis in a patient with head and neck carcinoma treated with nivolumab: a rare but severe immune-related adverse event","volume":"281","author":"Ohno","year":"2024","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jvscit.2025.101824_bib12","article-title":"A rare case of large-vessel vasculitis following checkpoint inhibitor therapy and pegfilgrastim","volume":"2022","author":"Mort","year":"2022","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.jvscit.2025.101824_bib13","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.2169\/internalmedicine.8688-21","article-title":"Inflammatory thoracic aortic aneurysm in a patient with advanced lung adenocarcinoma treated with pembrolizumab","volume":"61","author":"Ninomiya","year":"2022","journal-title":"Intern Med"},{"key":"10.1016\/j.jvscit.2025.101824_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7971169","article-title":"A case report of immune checkpoint inhibitor-induced aortitis treated with tocilizumab","volume":"2022","author":"Bloomer","year":"2022","journal-title":"Case Reports Immunol"},{"key":"10.1016\/j.jvscit.2025.101824_bib15","article-title":"A cautionary note on pembrolizumab use in patients with ascending aortic aneurysms","volume":"11","author":"Khan","year":"2024","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.jvscit.2025.101824_bib16","article-title":"Type and frequency of immune-related adverse reactions in patients treated with pembrolizumab (Keytruda), a monoclonal antibody directed against PD-1, in advanced melanoma at a single institution","volume":"68","author":"Pinkston","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jvscit.2025.101824_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5348\/100092Z10NL2021CR","article-title":"Abdominal aortitis with immune checkpoint inhibition","volume":"7","author":"Liguori","year":"2021","journal-title":"J Case Rep Images Oncol"},{"key":"10.1016\/j.jvscit.2025.101824_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.1291","article-title":"Large-vessel vasculitis induced by pegfilgrastim and immune checkpoint inhibitor in a patient with small-cell lung cancer","volume":"12","author":"Shiraha","year":"2024","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.jvscit.2025.101824_bib19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1159\/000534931","article-title":"Pegfilgrastim-Induced aortitis in a patient with small-cell lung cancer who received immunotherapy Combined with chemotherapy","volume":"16","author":"Ito","year":"2023","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jvscit.2025.101824_bib20","first-page":"5","article-title":"Rheumatology case report immune-related aortitis associated with ipilimumab","volume":"11","author":"Ban","year":"2017","journal-title":"Rheumatologist"},{"key":"10.1016\/j.jvscit.2025.101824_bib21","article-title":"Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course","volume":"38","author":"Chanson","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jvscit.2025.101824_bib22","first-page":"100454","article-title":"Granulocyte-colony stimulating factor-associated aortitis in cancer: a systematic literature review","volume":"29","author":"Hoshina","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.jvscit.2025.101824_bib23","article-title":"Characteristics and outcomes in a prospective cohort of patients with histologically diagnosed aortitis","volume":"3","author":"Goldhar","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/j.jvscit.2025.101824_bib24","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s10067-018-4177-0","article-title":"Vasculitis associated with immune checkpoint inhibitors-a systematic review","volume":"37","author":"Daxini","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jvscit.2025.101824_bib25","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1200\/JCO.2017.77.6385","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Brahmer","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvscit.2025.101824_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1710-1492-9-30","article-title":"A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Journal of Vascular Surgery Cases, Innovations and Techniques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468428725001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468428725001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:24:48Z","timestamp":1753485888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468428725001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2468428725001066"],"URL":"https:\/\/doi.org\/10.1016\/j.jvscit.2025.101824","relation":{},"ISSN":["2468-4287"],"issn-type":[{"value":"2468-4287","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-associated abdominal aortitis and retroperitoneal fibrosis after treatment with nivolumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery Cases, Innovations and Techniques","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvscit.2025.101824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"101824"}}